We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Beckman Coulter, Inc. | NYSE:BEC | NYSE | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 83.47 | 0.00 | 01:00:00 |
From May 2019 to May 2024
The European Commission's antitrust body said Friday it has cleared U.S. technology firm Danaher Corp. (DHR) to buy medical testing company Beckman Coulter (BEC).
The Commission concluded that the merged entity would continue to have significant rivals in the fields it covers and therefore the deal wouldn't harm competition in the European Union.
-By Laurence Norman, Dow Jones Newswires; 32-2741-1481; laurence.norman@dowjones.com
1 Year Beckman Coulter Chart |
1 Month Beckman Coulter Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
